Publication
Oncological impact of adjuvant chemotherapy after rectal cancer excision in the era of FOLFIRINOX-based TNT: A pooled post-hoc analysis of GRECCAR4-PRODIGE23.
Quentin Denost, Philippe Rouanet, Eva Teruel, Christophe Borg, Bernard Lelong, Pierre-Luc Etienne, Philippe Maingon, Emmanuel Rio, Jean-Jacques Tuech, Barbara Noiret, Stéphanie Nougaret, Veronica Pezzela, Sophie Gourgou, Thierry Conroy, GRECCAR and PRODIGE Study Groups
- Source
- PubMed
- Retrieved
- Sep 19, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260919-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
BACKGROUND: The role of adjuvant chemotherapy (AC) after total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC) remains controversial, mainly based on colon cancer protocols, with recent validation of the equivalence of the 3- and 6-month CT regimens. The aim of this study is to…
Read on PubMedLinked entities
Linked entities (3)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Validated 2
- trialNCT01333709registry_reference1.00
- trialNCT01804790registry_reference1.00
Candidate 1
- cancerMalignant Rectal Neoplasmdictionary0.60
Registered trialsNCT01333709NCT01804790
Curated evidence
Evidence citing this paper (0)
Data not yet available